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A myelolipoma  is  a  rare  benign  lesion  often  discovered  by  chance  during  a  tomodensit-
ometry  (CT)  examination  of  the  abdomen.  It  is  classically  located  in  the  adrenal  glands
and  is  easily  recognised  due  to  its  contingent  of  adipocytes  [1].  Extra-adrenal  forms  are
unusual  and  cause  diagnostic  difﬁculties  even  with  histopathology.  We  report  here  the  case
of  a  male  patient  with  a  retroperitoneal  extra-adrenal  myelolipoma,  which  presented  very
much  like  a  well-differentiated  liposarcoma.  This  observation  is  the  moment  to  recall  the
imaging  characteristics  of  retroperitoneal  fatty  tumours  and  to  emphasize  the  major  role
of  identifying  cytogenetic  and  molecular  abnormalities  in  characterising  them.
Observation
A  55-year-old  man,  with  no  notable  medical  history  apart  from  mood  and  behavioural
disorders,  was  admitted  to  the  dermatology  unit  for  management  of  exanthema  of  the  left
leg  that  had  been  evolving  for  several  months.  He  had  no  somatic  symptoms  apart  from
pruritus  associated  with  his  skin  rash.
Abdominal  ultrasonography,  performed  to  look  for  the  cause  of  the  exanthema,  revealed
the  presence  of  a  hyperechoic  mass  under  the  right  kidney.  An  abdominal  CT  examina-
tion  conﬁrmed  that  there  was  a voluminous,  well-delineated,  right  retroperitoneal  mass,
of  10  cm  at  its  widest  point,  predominantly  of  dense  fatty  material,  with  a  second  tis-
sue  component  in  the  form  of  poorly  demarcated  layers,  enhanced  following  intravenous
injection  of  an  iodinated  contrast  agent  (Fig.  1).  The  kidneys  and  adrenal  glands  were
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Figure 1. Abdominopelvic CT scan following injection of iodinated contrast agent. It shows a well-delineated right subrenal retroperitoneal
mass, surrounded by a ﬁne capsule. Two components are visible: a predominant one of fat and the other of tissue, inﬁltrating the fat and
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right  adrenal  gland,  limited  by  a  connective  capsule  andwith indistinct contours (a and b). Reformation (b) shows the norm
mass (head of arrow).
normal.  The  diagnosis  suggested  was  of  a  malignant
retroperitoneal  tumour,  such  as  a  well-differentiated
liposarcoma  (WLD).  Several  CT  guided  percutaneous  micro-
biopsy  samples  were  taken  to  conﬁrm  this.
The  histological  analysis  revealed  a  lesion  formed  of
mature  adipocytes  and  ﬁbrous  septa,  altered  by  oedema
and  polymorphous  inﬂammatory  cells.  There  was  no  cellular
atypia,  and  the  immunohistochemical  study  with  anti-MDM2
and  anti-CDK4  antibodies  was  negative.  Since  there  were  no
histological  and  phenotypic  characteristics  of  liposarcoma,
it  was  hypothesised  that  the  mass  was  a  simple  lipoma;
however,  the  quantity  of  tissue  analysed  was  small  and  the
radiological  characteristics  leaned  more  towards  a  malig-
nant  lesion.
Faced  with  this  inconsistency  between  the  anatomical
and  radiological  ﬁndings,  abdominal  MRI  was  performed.  It
did  not  provide  any  new  semeiotic  element  but  conﬁrmed
the  coexistence  of  a  fatty  component  with  another  quantity
Figure 2. Abdominal MRI. Within the retroperitoneal mass, the fatty com
it looks identical to that of the subcutaneous fat (a), and is cancelled out 
tissue component (white arrow) is moderately enhanced after injecting c
sequence, TR: 550 ms, TE: 11 ms; b: GRE (rapid gradient echo) T1-we
selective saturation of the fat signal (FatSat) and after injection of gado
c
g
rht adrenal gland (arrow) and separated from it, the extra-adrenal
f  tissue  forming  zones  of  moderate  enhancement,  giving
eight  to  the  hypothesis  of  a  malignant  fatty  lesion  (Fig.  2).
Since  there  was  no  speciﬁc  diagnosis  based  on  the  histol-
gy,  but  with  radiological  and  probabilistic  reasons  (the  high
robability  of  malignancy  of  a  retroperitoneal  fatty  mass)
or  considering  it  to  be  a  liposarcoma,  it  was  decided  follow-
ng  a  multidisciplinary  consultation  to  undertake  surgery  for
nitial  management  of  a well-differentiated  retroperitoneal
iposarcoma.
R0  enlarged  exeresis  of  the  retroperitoneal  mass  was
ndertaken  with  right  nephrectomy  and  monobloc  right
emicolectomy.  The  pathological  anatomy  analysis  of  the
ass  conﬁrmed  the  presence  of  a  well-deﬁned  lesion  of
0.5  × 7 ×  3.5  cm,  not  adhering  to  either  the  kidney  or  theponent (black arrow) can be perfectly identiﬁed: in T1 hypersignal
(b) by the technique of selective saturation of the fat (FatSat). The
ontrast agent (b): a: TSE (turbo spin echo) T1-weighted transverse
ighted transverse sequence, TR: 3.2 ms, TE: 1.1 ms,  : 50◦, with
linium (Dotarem®).
omposed  of  both  adipocytes  and  a  haemopoietic  contin-
ent,  which  therefore  produced  the  diagnosis  of  ectopic
etroperitoneal  myelolipoma  (Fig.  3).
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Figure 3. Macroscopic photograph of the ablated material after
surgery showing the relationship between the tumour, the right kid-
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Rey and the right colon together with the tumoural fat (arrow) and
issue (head of arrow) components.
iscussion
 myelolipoma  is  a  rare  benign  tumour,  composed  of  mature
dipose  tissue  associated  in  variable  proportions  with  nor-
al  haemopoietic  tissue.
It  is  classically  asymptomatic  and  found  in  a  normal
drenal  gland.  It  presents  no  problem  of  diagnosis  for  imag-
ng  because  it  is  the  only  adrenal  tumour  composed  of  a
uantity  of  adipose  tissue  which  can  always  be  recognised:  in
T,  the  spontaneous  density  of  this  tissue  is  lower  than  —30
ounsﬁeld  units,  and  in  MRI,  its  signal  is  hyperintense  in  T1
eighting  and  is  cancelled  out  following  selective  saturation
f  the  signal  from  the  fat  by  FatSat  (a  signal  parallel  to  that
f  mature  fat).  Chemical  shift  sequences  do  not  objectify
ny  reduction  in  the  opposed-phase  signal  (unlike  suprarenal
denomas  which  are  composed  of  non-adipocyte  cells  and
re  more  or  less  rich  in  intracellular  lipids)  [2].  It  is  necessary
nd  adequate,  therefore,  to  detect  adipose  tissue  within  an
drenal  nodule  to  be  able  to  diagnose  an  isolated  adrenal
yelolipoma,  a  lesion  that  does  not  require  any  treatment
r  special  monitoring  [1].
Diagnosing  a  retroperitoneal  extra-adrenal  myelolipoma,
hich  is  much  rarer,  is  more  difﬁcult.  A  fatty  retroperitoneal
ass  could  essentially  be  a  retroperitoneal  liposarcoma,
n  adrenal  myelolipoma,  a  renal  angiomyolipoma  or  a
etroperitoneal  teratoma.  If  there  is  no  speciﬁc  aetiological
uidance,  samples  must  be  taken  for  histological  analysis.
In  our  patient,  it  was  not  possible  from  the  histological
tudy  of  the  ﬁrst  samples  taken  percutaneously  to  diagnose
 myelolipoma,  since  the  three  haemopoietic  lineages  were
ot  detected  in  the  sample.  At  the  end  of  our  investigations,
e  therefore  discussed  differential  diagnoses  of  lipoma  and
DL.
It  is  necessary  to  be  able  to  differentiate  these  two  enti-
ies  because  that  decides  the  management.  Indeed,  WDL,
nlike  lipoma,  has  a  risk  of  locoregional  recurrence  and
otential  for  transforming  into  a  very  highly  malignant  sar-
oma.  Wide  exeresis  enlarged  to  the  adjacent  organs  is
herefore  recommended  [3].
Imaging  contributes  to  this  differentiation:  indeed,
umour  size  greater  than  10  cm,  the  presence  of  septa  of
[
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hickness  more  than  2  mm  or  a  nodular  zone,  and  a  fatty
omponent  less  than  75%,  are  highly  suggestive  of  malig-
ancy  [4].  For  Gaskin  and  Helms,  the  sensitivity  of  MRI
s  100%  in  diagnosing  WLD,  but  its  speciﬁcity  is  only  83%,
ecause  certain  simple  lipomas  or  lipoma  variations  cannot
e  distinguished  from  a  WLD  [5].  Any  fatty  lesion  that  does
ot  look  like  a  simple  lipoma  in  imaging  (or  have  the  charac-
eristic  appearance  of  certain  benign  fatty  tumours)  should
e  biopsied  to  clarify  what  kind  it  is.
In  histology,  distinguishing  a  lipoma  from  a  WLD  can  be
ifﬁcult:  it  relies  on  the  presence,  within  the  WDL,  of  imma-
ure  adipose  cells  (lipoblasts)  and  abnormal  cells,  which  are
ometimes  few  in  number  and  heterogeneously  distributed.
or  some  years,  differential  diagnosis  between  lipoma  and
DL  has  been  facilitated  by  cytogenetics  and  molecular  biol-
gy  [6],  because  chromosomal  and  molecular  abnormalities
ave  been  consistently  and  speciﬁcally  identiﬁed  in  liposar-
oma  cells.  These  abnormalities  are  supernumerary,  giant
hromosomes  and  ring  chromosomes  that  carry  an  ampliﬁ-
ation  of  the  MDM2  gene,  causing  hyperexpression  of  the
rotein,  detectable  by  immunohistochemistry.  It  is  there-
ore  possible  to  detect  a  speciﬁc  molecular  abnormality  of
iposarcomas  on  a  routine  basis.
The  diagnostic  value  of  the  absence  in  our  patient  of  any
mpliﬁcation  of  the  MDM2  gene  was  not  known.  The  hypoth-
sis  of  a  WDL  was  considered  the  most  probable  diagnosis,
hereas  it  should  have  been  excluded,  with  consequences
n  the  extent  of  surgical  ablation:  the  right  colectomy  and
ven  the  nephrectomy  could  have  been  avoided.
Two  lessons  have  been  drawn  from  this  observation.
Firstly,  there  are  atypical  presentations  of  myelolipoma,
n  particular  occurrence  in  extra-adrenal  locations,  the
nusual  nature  of  which  justiﬁes  histological  evidence.  This
s  obtained  provided  that  the  samples  analysed  contain  the
hree  haemopoietic  lines,  sometimes  well  concealed  within
he  adipose  tissue.
Secondly,  this  clinical  case  illustrates  the  contribution
ade  by  cytogenetics  and  molecular  biology  to  the  diagnosis
f  fatty  tumours.  It  is  indeed  possible  to  conﬁrm  or  quash
he  diagnosis  of  liposarcoma  owing  to  immunohistochemical
etection  of  hyperexpression  of  the  protein  MDM2.
Finally,  we  would  like  to  highlight  another  advantage
f  the  techniques  related  to  MDM2:  they  allow  a  dediffer-
ntiated  liposarcoma  to  be  recognised,  and  thus  certain
on-differentiated  mesenchymal  tumours  to  be  connected
o  the  adipocyte  line,  which,  by  default,  are  qualiﬁed
s  malignant  ﬁbrous  histiocytomas,  sarcomas  with  a  much
leaker  prognosis.
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